Max Piffoux
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Extracellular vesicles in disease
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- Circular RNAs in diseases
Papers in
-
- Extracellular vesicles in disease 15
- RNA Interference and Gene Delivery 8
-
- MicroRNA in disease regulation 7
- Co-authors
- Florence Gazeau (16 shared papers)Amanda Silva (15 shared papers)Claire Wilhelm (12 shared papers)David Tareste (2 shared papers)Philippe A. Cassier (1 shared paper)Jeanne Volatron (4 shared papers)Julien Branchu (1 shared paper)Gabriel Rahmi (3 shared papers)
- Journals
- Advanced Drug Delivery Reviews (3 papers)Nanoscale (3 papers)Pharmaceutics (2 papers)Clinical and Translational Radiation Oncology (2 papers)Drug Delivery (1 paper)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Max Piffoux
32 papers receiving 1.2k citations
Max Piffoux's Hit Papers
Peers
Comparison fields: 5 of 96
- Cancer Research 414
- Molecular Biology 913
- Biomaterials 112
- Structural Biology 11
- Biomedical Engineering 305
Countries citing papers authored by Max Piffoux
This map shows the geographic impact of Max Piffoux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Piffoux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Piffoux more than expected).
Fields of papers citing papers by Max Piffoux
This network shows the impact of papers produced by Max Piffoux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Piffoux. The network helps show where Max Piffoux may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Piffoux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems Hit paper breakdown → | 2018 | 394 |
| 2 | 2020 | 138 | |
| 3 | 2021 | 128 | |
| 4 | 2018 | 97 | |
| 5 | 2021 | 73 | |
| 6 | 2023 | 64 | |
| 7 | 2018 | 62 | |
| 8 | 2017 | 40 | |
| 9 | 2020 | 32 | |
| 10 | 2018 | 26 | |
| 11 | 2021 | 24 | |
| 12 | 2021 | 19 | |
| 13 | 2021 | 17 | |
| 14 | 2020 | 17 | |
| 15 | 2022 | 12 | |
| 16 | 2024 | 10 | |
| 17 | 2024 | 10 | |
| 18 | 2024 | 9 | |
| 19 | 2016 | 9 | |
| 20 | 2022 | 7 |
About Max Piffoux
Max Piffoux is a scholar working on Molecular Biology, Cancer Research, Biomedical Engineering, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 36 papers that have together received 1.2k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (15 papers), RNA Interference and Gene Delivery (8 papers), MicroRNA in disease regulation (7 papers), Advances in Oncology and Radiotherapy (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Nanoplatforms for cancer theranostics (3 papers), Photoacoustic and Ultrasonic Imaging (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Cancer Research (414 citations), Molecular Biology (913 citations), Biomaterials (112 citations), Structural Biology (11 citations) and Biomedical Engineering (305 citations). Max Piffoux has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Florence Gazeau, Amanda Silva, Claire Wilhelm, David Tareste, Philippe A. Cassier, Jeanne Volatron, Julien Branchu, Gabriel Rahmi, Alba Nicolás‐Boluda and Sophie Richard. Their work appears in journals such as Advanced Drug Delivery Reviews, Nanoscale, Pharmaceutics, Clinical and Translational Radiation Oncology and Drug Delivery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.